You are currently viewing a new version of our website. To view the old version click .

Evaluation of COVID-19 Booster Vaccine Effects

This special issue belongs to the section “Coronaviruses“.

Special Issue Information

Dear Colleagues,

Three years have passed since the COVID-19 outbreak, which has claimed millions of lives. Vaccination is considered as the most effective approach for the prevention and control of COVID-19. However, the protective efficacy of the COVID-19 vaccines weakens over time after vaccination. Additionally, the effectiveness of the vaccines dramatically declines for different variants. Booster vaccination has shown a higher level of antibody production. Therefore, booster vaccines have been administered in order to improve the immunization level of various populations. The effects and durability of booster vaccination need to be evaluated and monitored frequently. This Special Issue provides a platform for communication and discussion on this important issue. This Special Issue will feature original research articles and reviews related to, but not limited to, epidemiology studies, vaccine efficacy (effectiveness) evaluation, new delivering systems for vaccines, development of new vaccines, prediction models to evaluate vaccine effects, pathogens, interactions between viruses and hosts, molecular mechanisms, molecular evolution, and so on.

Dr. Dingmei Zhang
Dr. Bingqian Qu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • SARS-CoV-2
  • vaccine
  • evaluation of vaccine efficacy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Viruses - ISSN 1999-4915